Oncologic colorectal surgery in the time of the COVID-19 pandemic
Editorial

Oncologic colorectal surgery in the time of the COVID-19 pandemic

Mateusz Jagielski1, Jacek Piątkowski1, Ewa Sztuczka1,2, Marek Jackowski1

1Department of General, Gastroenterological and Oncological Surgery, Collegium Medicum Nicolaus Copernicus University, Toruń, Poland; 2Cuiavian University, Włocławek, Poland

Correspondence to: Mateusz Jagielski, MD, PhD, Ass. Prof. Department of General, Gastroenterological and Oncological Surgery, Collegium Medicum Nicolaus Copernicus University, 53-59 Św. Józefa St, 87-100 Toruń, Poland. Email: matjagiel@gmail.com.

Received: 23 March 2021; Accepted: 11 April 2021; Published: 30 June 2021.

doi: 10.21037/dmr-21-32


In December 2019 in Wuhan, China the first cases of disease currently known as coronavirus disease 2019 (COVID-19) were stated (1,2). It was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1,2). In the following months the disease spread over all continents and on 11th March 2020 World Health Organization (WHO) announced the pandemic of COVID-19 (3). COVID-19 is a disease of high infectivity and mortality rate depends on quality of health care in particular countries (4,5). Epidemic situation related to COVID-19 is changing dynamically all over the world. Increased focus on pandemic related issues has a negative effect on health care in other branches of medicine. It also affects oncological patients.

Colorectal cancer (CRC) is among the commonest types of tumor of the world (6-8). Despite of development of different oncological treatment methods, the surgical resection remains the gold standard treatment for patients with CRC (7-9). Recently, many minimally invasive surgical techniques have been proposed for abdominal surgery, including colorectal surgery. Compared with conventional surgical treatment, minimally invasive techniques for the treatment of noninvasive CRC, such as laparoscopic methods, shorten the duration of hospitalization and improve short-term outcomes without affecting the outcomes of oncological treatment (10-12). Minimally invasive access often facilitates the creation of a primary intestinal anastomosis without the need for stoma formation (10-13).

We have read the article of Rocca et al. titled “Oncologic colorectal surgery in a general surgery unit of a small region of Italy—a successful “referral Centre Hub & Spoke Learning Program” very important to reduce mobility in the Covid-19 era” with great interest (6). The authors in the retrospective study based on their personal experience presented promising results of “Teaching/Learning Model of Hub & Spoke Collaboration” between their medical center and other referral center for colorectal surgery (6). The aim of this pilot study was to share an experience of a single center from an internal area of southern Italy who was trying to reduce migration and costs while ensuring the standard of care in oncologic colorectal surgery (6). Both reduction of health migration and costs, as well as decrease in waiting times for surgery are important factors in challenging times of COVID-19 pandemic. Despite presentation of the results, the authors did not draw any significant conclusions, that may be obvious for the reader but should nevertheless be emphasized by the authors (6). Nevertheless, in our opinion the issue described by Rocca et al. is very important and up to date (6).

In our medical center majority of surgical procedures in patients with CRC is performed laparoscopically (13,14). Nevertheless, in the time of the COVID-19 pandemic, oncological treatment of these patients is challenging. In this difficult period, we adopted some clinical guidelines in oncological treatment of patients with CRC in our referral center. The basis of our guidelines was to maintain the continuity of multidisciplinary treatment of patients with CRC. Another demand our guidelines had to meet was the facilitation of the correct and fast oncological diagnosis and treatment with the intention to maintain radical treatment. In all possible cases of patients with CRC our aim is to reduce the duration of hospital stay—shortening the exposure time reduces the risk of transmission of COVID-19 infection. In-hospital Enhanced Recovery After Surgery (ERAS) (15) procedures should be maintained as they allow to shorten the time of hospitalization. Above mentioned laparoscopic methods of treatment of patients with CRC implemented in our center also shorten the duration of hospitalization. The implementation of these guidelines significantly improves quality of oncological care in the time of the COVID-19 pandemic.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was a standard submission to the journal. The article has undergone external peer review.

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/dmr-21-32). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20. [Crossref] [PubMed]
  2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. [Crossref] [PubMed]
  3. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
  4. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9. [Crossref] [PubMed]
  5. Baud D, Qi X, Nielsen-Saines K, et al. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis 2020;20:773. [Crossref] [PubMed]
  6. Rocca A, Avella P, Scacchi A, et al. Oncologic colorectal surgery in a general surgery unit of a small region of Italy—a successful “referral Centre Hub & Spoke Learning Program” very important to reduce mobility in the Covid-19 era. Dig Med Res 2020;3:44. [Crossref]
  7. van de Velde CJ, Boelens PG, Borras JM, et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer 2014;50:e1-1.e34. [Crossref] [PubMed]
  8. Lee M, Gibbs P, Wong R. Multidisciplinary Management of Locally Advanced Rectal Cancer-an Evolving Landscape? Clin Colorectal Cancer 2015;14:251-61. [Crossref] [PubMed]
  9. van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 2018;391:2537-45. [Crossref] [PubMed]
  10. Pędziwiatr M, Małczak P, Mizera M, et al. There is no difference in outcome between laparoscopic and open surgery for rectal cancer: a systematic review and meta-analysis on short- and long-term oncologic outcomes. Tech Coloproctol 2017;21:595-604. [Crossref] [PubMed]
  11. Nienhüser H, Heger P, Schmitz R, et al. Short- and long-term oncological outcome after rectal cancer surgery: a systematic review and meta-analyzis comparing open versus laparoscopic rectal cancer surgery. J Gastrointest Surg 2018;22:1418-33. [Crossref] [PubMed]
  12. Branda ME, Sargent DJ, Boller AM, et al. Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg 2019;269:589-95. [Crossref] [PubMed]
  13. Piątkowski J, Jackowski M, Nowak M, et al. TaTME: 2 Years of Experience of a Single Center Surg Laparosc Endosc Percutan Tech 2019;9:64-8.
  14. Jagielski M, Piątkowski J, Jarczyk G, et al. Transrectal endoscopic drainage with vacuum-assisted therapy in patients with anastomotic leaks following rectal cancer resection. Surg Endosc 2021; Epub ahead of print. [Crossref] [PubMed]
  15. Ahmed J, Khan S, Lim M, et al. Enhanced recovery after surgery protocols - compliance and variations in practice during routine colorectal surgery. Colorectal Dis 2012;14:1045-51. [Crossref] [PubMed]
doi: 10.21037/dmr-21-32
Cite this article as: Jagielski M, Piątkowski J, Sztuczka E, Jackowski M. Oncologic colorectal surgery in the time of the COVID-19 pandemic. Dig Med Res 2021;4:24.